Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Porzio, , Vincenza,
DOB: 13-SEP-1965 (Age: 60)
Gender: female
Address:
Piazza Allegra, 720
36040 Grumolo Pedemonte (Italy)
ID: 9988-341158-1 (ECI)
Report
Date: 13-FEB-2020
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Villa Margherita
(Italy)
Specimen
Collected: 13-FEB-2020

Chemistry

Test 13-FEB-2020 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.4 H 4 - 6 %
Glucose [Mass/volume] in Blood 91.4 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 8.6 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.8 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 8.8 8.5 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 143.8 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.3 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 110.9 H 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 20.6 L 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 147.4 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 141.7 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 66.6 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 52.4 50 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated HbA1c (6.4%), indicating impaired glucose metabolism or possible prediabetes/diabetes, despite normal fasting glucose. Chloride is slightly elevated and total CO₂ is mildly decreased, which may suggest a mild metabolic acidosis. Renal function, electrolytes, and lipid profile are within normal limits. Clinical correlation and follow-up for glycemic control and acid-base status are recommended.